An Engine for New Medicines

The Calibr-Skaggs Institute for Innovative Medicines, a nonprofit research institute founded by Scripps Research President and CEO Peter Schultz, joined Scripps Research in 2018 as its drug discovery division.

As a world-class nonprofit “bench to bedside” drug discovery engine, Calibr delivers groundbreaking solutions to unmet medical needs by uniting the creativity of fundamental discovery with highly focused R&D capabilities and expertise.